What is the role of the Hepatiq radiologic image processing system in the evaluation for hepatitis B (HBV) (Hep B) infection?

Updated: Aug 01, 2018
  • Author: Nikolaos T Pyrsopoulos, MD, PhD, MBA, FACP, AGAF; Chief Editor: BS Anand, MD  more...
  • Print
Answer

On December 17, 2014, the FDA gave marketing approval for the Hepatiq radiologic image processing system. [51, 52] The software application uses quantitative analysis of nuclear medicine liver-spleen images to determine the severity of the liver disease and to predict the clinical outcomes. [52] The developer notes that Hepatiq "automates the Quantitative Liver Spleen Scan (QLSS) that has been proven to be an accurate predictor of clinical outcomes in the recently concluded HALT-C [epatitis C ntiviral ong-term reatment against irrhosis] trial." [52] The HALT-C trial was a multicenter, randomized controlled study that evaluated whether long-term interferon would suppress HCV, prevent progression to cirrhosis, prevent liver cancer, and reduce the need for liver transplantation. [53]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!